ASH1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.89102075612391E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.85070000050069E-07 |
Normal-vs-Stage2 |
3.38320000015102E-07 |
Normal-vs-Stage3 |
1.4432899320127E-15 |
Normal-vs-Stage4 |
1.62703184258817E-12 |
Stage1-vs-Stage2 |
1.689430E-01 |
Stage1-vs-Stage3 |
1.86756999999149E-05 |
Stage1-vs-Stage4 |
1.1119999999698E-06 |
Stage2-vs-Stage3 |
1.194770E-01 |
Stage2-vs-Stage4 |
3.794500E-02 |
Stage3-vs-Stage4 |
4.193000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.33368879776208E-12 |
Normal-vs-AfricanAmerican |
3.6998999974891E-08 |
Normal-vs-Asian |
1.363770E-01 |
Caucasian-vs-AfricanAmerican |
3.855600E-01 |
Caucasian-vs-Asian |
3.130400E-01 |
AfricanAmerican-vs-Asian |
2.311000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.36077865326479E-14 |
Normal-vs-Female |
6.87159995571562E-09 |
Male-vs-Female |
4.688400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.24269999999915E-05 |
Normal-vs-Age(41-60Yrs) |
1.12770000004758E-08 |
Normal-vs-Age(61-80Yrs) |
1.64523950019202E-12 |
Normal-vs-Age(81-100Yrs) |
1.50779999996686E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.698600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.898800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.826600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.365700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.313640E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.483200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.349800E-01 |
Normal-vs-Grade 2 |
5.06380000042661E-07 |
Normal-vs-Grade 3 |
1.626032641866E-12 |
Normal-vs-Grade 4 |
4.44089209850063E-16 |
Grade 1-vs-Grade 2 |
4.918300E-02 |
Grade 1-vs-Grade 3 |
2.226800E-04 |
Grade 1-vs-Grade 4 |
4.14810000015642E-07 |
Grade 2-vs-Grade 3 |
2.846700E-04 |
Grade 2-vs-Grade 4 |
5.42039999551491E-08 |
Grade 3-vs-Grade 4 |
1.752390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.24259999999088E-05 |
Normal-vs-ccB subtype |
1.88771220877015E-12 |
ccA subtype-vs-ccB subtype |
2.21759999996518E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.13690176664727E-11 |
Normal-vs-N1 |
1.161410E-04 |
N0-vs-N1 |
4.492800E-01 |
|
|